World Coronavirus Dispatch: Moderna in S&P 500 after stock's stellar show

YouTube pulls Bolsonaro videos for misinformation, Covid could have been circulating in Italy in October 2019, but it's inconclusive, and other pandemic-related news across the globe

Moderna joins top S&P 500 firms as stock value triples

Moderna Inc joined the US benchmark S&P 500 after its stock advanced over 30 per cent in four trading sessions. Its shares touched $321.11, another fresh high, with a market value of $129 billion on Tuesday. Moderna is the S&P index’s best-performing stock this year by a mile. The move caps the drugmaker’s transformation from an early-stage biotech to a vaccine maker supplying Covid shots to the world. With a gain of just over 207 per cent so far in 2021, Moderna’s share performance tops the index's existing leaders.